International Business Analysis Project

How well do GSK assess risks over the Drug Development Phase (DDP) and Sales Phase with respect to maximizing shareholder value?  How well do GSK assess risks over the Drug Development Phase (DDP) and Sales Phase with respect to maximizing shareholder value? .